$NAUT 8-K SEC Filings

Filed On	Filing
11 Sep 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement Nautilus Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with TD Securities (USA) LLC (“TD Cowen”), as follows:
28 Jul 2026	8-K: Results of Operations and Financial Condition
18 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
28 Apr 2026	8-K: Results of Operations and Financial Condition
26 Feb 2026	8-K: Results of Operations and Financial Condition
04 Nov 2025	8-K: Other Events
28 Oct 2025	8-K: Results of Operations and Financial Condition
31 Jul 2025	8-K: Results of Operations and Financial Condition
23 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
02 May 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
29 Apr 2025	8-K: Results of Operations and Financial Condition
27 Feb 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
31 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
29 Oct 2024	8-K: Results of Operations and Financial Condition
30 Jul 2024	8-K: Results of Operations and Financial Condition
13 Jun 2024	8-K: Submission of Matters to a Vote of Security Holders
30 Apr 2024	8-K: Results of Operations and Financial Condition
28 Feb 2024	8-K: Entry into a Material Definitive Agreement
28 Feb 2024	8-K: Results of Operations and Financial Condition
14 Dec 2023	8-K: Other Events

Comments